多期肝脏MRI用于识别肝细胞癌的巨梁状-团块型亚型
本回顾性研究纳入2008年1月至2018年2月间接受手术切除且术前行多期增强MRI的152例肝细胞癌患者(152个病灶),其中26个(17%)为巨梁状-团块型(MTM-HCC)。LASSO及多因素logistic回归显示,显著坏死、血清AFP>100 ng/mL、BCLC B或C期是MTM-HCC的独立预测因素;显著坏死的敏感度为65%、特异度为93%。仅卫星结节与早期及总体复发独立相关。
要点
- 显著坏死识别MTM-HCC的敏感度为65%(17/26),特异度为93%(117/126)。
- 显著坏死、AFP>100 ng/mL、BCLC B或C期是MTM-HCC的独立预测因素。
- 卫星结节是早期复发(HR=3.7)和总体复发(HR=3.0)的独立相关因素。
核心结论
- 在多期增强MRI上,显著坏死有助于以高特异度识别巨梁状-团块型肝细胞癌亚型。
研究设计与样本
- 回顾性研究纳入2008年1月至2018年2月接受手术切除、术前行多期增强MRI的152例肝细胞癌患者(152个病灶;中位年龄64岁,四分位距56-72岁;126例男性)。
- 采用LASSO惩罚及多因素logistic回归分析识别与MTM-HCC亚型相关的临床、生物学及影像特征。
- 采用Kaplan-Meier分析评估早期复发(2年内)和总体复发,多因素Cox回归确定复发预测因素。
关键影像表现/征象
- 152个肝细胞癌病灶中26个(17%)为MTM-HCC亚型。
- 显著坏死是MTM-HCC的独立预测因素(OR=32;95%CI:8.9,114;P<.001)。
- 仅卫星结节与早期复发(HR=3.7;95%CI:1.5,9.4;P=.006)和总体复发(HR=3.0;95%CI:1.3,7.2;P=.01)独立相关。
诊断标准与关键数值
- 显著坏死识别MTM-HCC的敏感度为65%(17/26;95%CI:44%,83%),特异度为93%(117/126;95%CI:87%,97%)。
- 血清AFP>100 ng/mL是MTM-HCC的独立预测因素(OR=4.4;95%CI:1.3,16;P=.02)。
- BCLC B或C期是MTM-HCC的独立预测因素(OR=4.2;95%CI:1.2,15;P=.03)。
临床应用与阅片要点
- 术前多期增强MRI发现显著坏死时,提示MTM-HCC可能,特异度达93%。
- 显著坏死的敏感度为65%,未出现显著坏死不能排除MTM-HCC。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Background The recently described "macrotrabecular-massive" (MTM) histologic subtype of hepatocellular carcinoma (HCC) (MTM-HCC) represents an aggressive form of HCC and is associated with poor survival. Purpose To investigate whether preoperative MRI can help identify MTM-HCCs in patients with HCC. Materials and Methods This retrospective study included patients with HCC treated with surgical resection between January 2008 and February 2018 and who underwent preoperative multiphase contrast material-enhanced MRI. Least absolute shrinkage and selection operator (LASSO)-penalized and multivariable logistic regression analyses were performed to identify clinical, biologic, and imaging features associated with the MTM-HCC subtype. Early recurrence (within 2 years) and overall recurrence were evaluated by using Kaplan-Meier analysis. Multivariable Cox regression analysis was performed to determine predictors of early and overall recurrence. Results One hundred fifty-two patients (median age, 64 years; interquartile range, 56-72 years; 126 men) with 152 HCCs were evaluated. Twenty-six of the 152 HCCs (17%) were MTM-HCCs. LASSO-penalized logistic regression analysis identified substantial necrosis, high serum α-fetoprotein (AFP) level (>100 ng/mL), and Barcelona Clinic Liver Cancer (BCLC) stage B or C as independent features associated with MTM-HCCs. At multivariable analysis, substantial necrosis (odds ratio = 32; 95% confidence interval [CI] = 8.9, 114; P < .001), high serum AFP level (odds ratio = 4.4; 95% CI = 1.3, 16; P = .02), and BCLC stage B or C (odds ratio = 4.2; 95% CI = 1.2, 15; P = .03) were independent predictors of MTM-HCC subtype. Substantial necrosis helped identify 65% (17 of 26; 95% CI: 44%, 83%) of MTM-HCCs (sensitivity) with a specificity of 93% (117 of 126; 95% CI: 87%, 97%). In adjusted models, only the presence of satellite nodules was independently associated with both early (hazard ratio = 3.7; 95% CI: 1.5, 9.4; P = .006) and overall (hazard ratio = 3.0; 95% CI: 1.3, 7.2; P = .01) tumor recurrence. Conclusion At multiphase contrast-enhanced MRI, substantial necrosis helped identify macrotrabecular-massive hepatocellular carcinoma subtype with high specificity. © RSNA, 2020.
引用
- Mulé S, Galletto Pregliasco A, Tenenhaus A, et al. Multiphase Liver MRI for Identifying the Macrotrabecular-Massive Subtype of Hepatocellular Carcinoma. Radiology. 2020. PMID: 32228294. doi:10.1148/radiol.2020192230
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。